153 related articles for article (PubMed ID: 10622035)
1. Clinical history of efavirenz.
Ruiz N
Int J Clin Pract Suppl; 1999 Jun; 103():3-7. PubMed ID: 10622035
[TBL] [Abstract][Full Text] [Related]
2. Update on study 006--EFV + AZT + 3TC versus the current 'standard of care' IDV + AZT + 3TC.
Staszewski S
Int J Clin Pract Suppl; 1999 Jun; 103():10-5. PubMed ID: 10622037
[TBL] [Abstract][Full Text] [Related]
3. DMP 266 now available.
Gilden D
GMHC Treat Issues; 1997 Sep; 11(9):5-6. PubMed ID: 11364751
[TBL] [Abstract][Full Text] [Related]
4. Amprenavir and efavirenz pharmacokinetics before and after the addition of nelfinavir, indinavir, ritonavir, or saquinavir in seronegative individuals.
Morse GD; Rosenkranz S; Para MF; Segal Y; Difrancesco R; Adams E; Brizz B; Yarasheski KE; Reichman RC
Antimicrob Agents Chemother; 2005 Aug; 49(8):3373-81. PubMed ID: 16048950
[TBL] [Abstract][Full Text] [Related]
5. New study shows efavirenz effective with d4T and 3TC.
AIDS Alert; 1999 May; 14(5):60. PubMed ID: 11366404
[TBL] [Abstract][Full Text] [Related]
6. Efavirenz plus zidovudine and lamivudine, efavirenz plus indinavir, and indinavir plus zidovudine and lamivudine in the treatment of HIV-1 infection in adults. Study 006 Team.
Staszewski S; Morales-Ramirez J; Tashima KT; Rachlis A; Skiest D; Stanford J; Stryker R; Johnson P; Labriola DF; Farina D; Manion DJ; Ruiz NM
N Engl J Med; 1999 Dec; 341(25):1865-73. PubMed ID: 10601505
[TBL] [Abstract][Full Text] [Related]
7. Efavirenz.
Adkins JC; Noble S
Drugs; 1998 Dec; 56(6):1055-64; discussion 1065-6. PubMed ID: 9878993
[TBL] [Abstract][Full Text] [Related]
8. Population pharmacokinetics and pharmacodynamics of efavirenz, nelfinavir, and indinavir: Adult AIDS Clinical Trial Group Study 398.
Pfister M; Labbé L; Hammer SM; Mellors J; Bennett KK; Rosenkranz S; Sheiner LB;
Antimicrob Agents Chemother; 2003 Jan; 47(1):130-7. PubMed ID: 12499180
[TBL] [Abstract][Full Text] [Related]
9. Efavirenz for HIV-1 infection in adults: an overview.
Fortin C; Joly V
Expert Rev Anti Infect Ther; 2004 Oct; 2(5):671-84. PubMed ID: 15482231
[TBL] [Abstract][Full Text] [Related]
10. Efavirenz (Sustiva) may equal or exceed protease inhibitor in initial antiretroviral combination.
James JS
AIDS Treat News; 1998 Jul; (No 299):1-3. PubMed ID: 11365599
[TBL] [Abstract][Full Text] [Related]
11. Efavirenz (SUSTIVA) expanded access begins October 1.
James JS
AIDS Treat News; 1997 Sep; (No 279):1-2. PubMed ID: 11364689
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and tolerability of long-term efavirenz plus nucleoside reverse transcriptase inhibitors for HIV-1 infection.
Tashima K; Staszewski S; Nelson M; Rachlis A; Skiest D; Stryker R; Bessen L; Overfield S; Ruiz N; Wirtz V
AIDS; 2008 Jan; 22(2):275-9. PubMed ID: 18097230
[TBL] [Abstract][Full Text] [Related]
13. Sustiva (efavirenz) is approved.
Vazquez E
Posit Aware; 1998; 9(6):17. PubMed ID: 11366471
[TBL] [Abstract][Full Text] [Related]
14. A review of abacavir and efavirenz: new antiretroviral drugs to treat HIV-1 infection.
Wolbach J; Capoccia K
Nurse Pract; 1999 Jun; 24(6):81-2, 87-90, 92. PubMed ID: 10431297
[No Abstract] [Full Text] [Related]
15. Didanosine, lamivudine-emtricitabine and efavirenz as initial therapy in naive patients.
Palacios R; Aguilar I; Hidalgo A; Santos J
Expert Rev Anti Infect Ther; 2006 Dec; 4(6):965-71. PubMed ID: 17181413
[TBL] [Abstract][Full Text] [Related]
16. Pharmacogenetics of long-term responses to antiretroviral regimens containing Efavirenz and/or Nelfinavir: an Adult Aids Clinical Trials Group Study.
Haas DW; Smeaton LM; Shafer RW; Robbins GK; Morse GD; Labbe L; Wilkinson GR; Clifford DB; D'Aquila RT; De Gruttola V; Pollard RB; Merigan TC; Hirsch MS; George AL; Donahue JP; Kim RB
J Infect Dis; 2005 Dec; 192(11):1931-42. PubMed ID: 16267764
[TBL] [Abstract][Full Text] [Related]
17. Dupont data supports earlier findings.
Slovick J
Posit Living; 1999 Nov; 8(10):45. PubMed ID: 11367331
[TBL] [Abstract][Full Text] [Related]
18. Review of NNRTIs: 'today and tomorrow'.
Katlama C
Int J Clin Pract Suppl; 1999 Jun; 103():16-20. PubMed ID: 10622038
[TBL] [Abstract][Full Text] [Related]
19. Don't mix Sustiva with Fortovase.
Posit Aware; 1998; 9(5):17. PubMed ID: 11365885
[TBL] [Abstract][Full Text] [Related]
20. Cerebrospinal fluid human immunodeficiency virus type 1 (HIV-1) suppression and efavirenz drug concentrations in HIV-1-infected patients receiving combination therapy.
Tashima KT; Caliendo AM; Ahmad M; Gormley JM; Fiske WD; Brennan JM; Flanigan TP
J Infect Dis; 1999 Sep; 180(3):862-4. PubMed ID: 10438381
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
